AbbVie (ABBV)

EBITDA Growth

98.11%

Quarterly · Period ending:

ABBV logo

ABBV EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported98.11%
ABBV Quarterly EBITDA YoY % (6.95% → 98.11%)
High-resolution chart · PNG

ABBV ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

AbbVie EBITDA Growth — Quarterly
Period endingEBITDA Growth
98.1123%
-16.0909%
903.5514%
-27.9951%
-13.1721%
-1.9826%
-86.1111%
2.9517%
-7.7278%
42.2821%
-32.2785%
-33.8032%
43.0229%
-58.1009%
-16.7204%
11.761%
-4.7009%
12.1537%
475.4002%
18.2405%
166.2651%
59.0995%
-71.3423%
81.7024%
-10.3779%
22.8888%
367.0535%
-15.587%
-39.9279%
-3.2948%
-183.3423%
27.7557%
-7.9907%
29.9305%
-29.5609%
6.8752%
14.6768%
20.9827%
10.4053%
24.4113%
28.9216%
33.9858%
439.4326%
102.629%
19.4379%
8.4244%
-141.1559%
-35.6113%
1.4854%
1.1053%
-8.9677%
-13.3623%
-0.825%
16.0755%
-10.5511%
399.1243%
-8.4659%
6.9488%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.